| scholarly article | Q13442814 |
| P50 | author | Kenji Mitsudo | Q42410897 |
| P2093 | author name string | Masahide Takahashi | |
| Tomoko Sato | |||
| Yoshiki Murakumo | |||
| Iwai Tohnai | |||
| Minoru Ueda | |||
| Sumitaka Hagiwara | |||
| Toshio Shigetomi | |||
| P433 | issue | 10 | |
| P921 | main subject | carcinogenesis | Q1637543 |
| P304 | page(s) | 1916-1923 | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | Cancer Science | Q326125 |
| P1476 | title | Up-regulation of CD109 expression is associated with carcinogenesis of the squamous epithelium of the oral cavity. | |
| P478 | volume | 99 |
| Q92632265 | A New Assessment of Thioester-Containing Proteins Diversity of the Freshwater Snail Biomphalaria glabrata |
| Q36041205 | CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma. |
| Q91151595 | CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro |
| Q55025939 | CD109 and squamous cell carcinoma. |
| Q43269447 | CD109 expression is upregulated in penile squamous cell carcinoma. |
| Q87642030 | CD109 is a potential target for triple-negative breast cancer |
| Q37688242 | CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX |
| Q28505691 | CD109 plays a role in osteoclastogenesis |
| Q47122926 | CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma |
| Q36246124 | CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts |
| Q38723891 | CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma |
| Q37439207 | Detection of a soluble form of CD109 in serum of CD109 transgenic and tumor xenografted mice |
| Q55004536 | Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer. |
| Q85491281 | Elevated Expression of CD109 in Esophageal Squamous Cell Carcinoma |
| Q90058950 | Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling |
| Q30303052 | Genome-wide association study of copy number variations (CNVs) with opioid dependence |
| Q35882587 | Genome-wide association study of toxic metals and trace elements reveals novel associations |
| Q21132376 | High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma |
| Q36641017 | Human platelet antigen genotyping and expression of CD109 (human platelet antigen 15) mRNA in various human cell types |
| Q101038789 | Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome |
| Q36925909 | Investigation of prognostic significance of CD109 expression in women with vulvar squamous cell carcinoma |
| Q49956275 | Myxofibrosarcoma primary cultures: molecular and pharmacological profile. |
| Q91967907 | Prognostic Significance of CD109 Expression in Patients with Ovarian Epithelial Cancer |
| Q38952650 | Proteomic identification of mammalian cell surface derived glycosylphosphatidylinositol-anchored proteins through selective glycan enrichment |
| Q37301807 | Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma |
| Q37696223 | Suppression of skin tumorigenesis in CD109-deficient mice |
Search more.